Avana

Basic Avana Information

• INN (International Nonproprietary Name): Avanafil
• Brand Names Available In Australia: Spedra (Menarini) — film‑coated tablets in foil blisters, available as 50 mg, 100 mg and 200 mg.
• ATC Code: G04BE11 (phosphodiesterase type‑5 inhibitor)
• Forms & Dosages: Oral tablets — 50 mg, 100 mg, 200 mg. No topical or parenteral forms known.
• Manufacturers In Australia: Menarini Group (distributor/supplier)
• Registration Status In Australia: Spedra listed and distributed in Australia; prescription classification applies.
• OTC / Rx Classification: Prescription only (Rx) in all markets.

Latest Research Findings — Austrian And EU Data

Patients often ask whether avanafil really works faster than older PDE5 inhibitors and whether it is better tolerated.

Recent Austrian and European analyses and post‑marketing reports (2019–2025) describe avanafil as a rapid‑onset PDE5 inhibitor with a favourable tolerability profile compared with older agents.

EMA authorisation for Spedra has been in place since 2013, and real‑world registries report onset as quick as around 15 minutes in many patients.

Austrian pharmacovigilance summaries note common adverse events such as headache, flushing and nasal congestion, while rare serious events relate mainly to inappropriate use with nitrates and cardiovascular instability.

Comparative signals seen in data include shorter time‑to‑erection, competitive discontinuation rates and fewer reported visual disturbances due to lower PDE6 cross‑reactivity than sildenafil.

Data Highlights: time‑to‑erection advantage, lower rates of visual disturbances versus sildenafil, discontinuation rates comparable to other PDE5 inhibitors.

Clinical Efficacy In Austria — Outcomes And Sozialversicherung Links

What results can a man expect in weeks after starting avanafil?

Pooled Austrian and EU evidence shows clinically meaningful improvements in erectile function scores within weeks when avanafil is used for erectile dysfunction.

The typical starting dose is 100 mg taken about 15 minutes before sexual activity, with adjustments to 50 mg or 200 mg based on tolerability and effect.

IIEF (International Index of Erectile Function)

Standard questionnaire measuring erectile function, orgasmic function, sexual desire, intercourse satisfaction and overall satisfaction.

SEP (Sexual Encounter Profile) Questions

Event‑based questions recording success of penetration and maintenance of erection during intercourse.

Austrian Sozialversicherung prescribing datasets indicate most avanafil prescriptions are private and paid out‑of‑pocket, with specialist urology referrals occurring when first‑line oral therapy fails.

E‑medikation records via the e‑card show higher uptake among men aged 40–65 in Vienna and Graz compared with many rural districts.

Adherence is often influenced by side‑effect burden, perceived stigma and availability of counselling in Apotheken, and the Österreichische Apothekerkammer supports pharmacist counselling and clear referral pathways.

Indications And Extended Uses

Patients ask whether avanafil is approved for anything beyond erectile dysfunction.

Regulatory indications per EMA and common Austrian practice limit avanafil (Spedra) to the treatment of erectile dysfunction in adult men.

Avanafil is not indicated for women or children.

• Approved Indication: Erectile dysfunction in adult men (on‑demand use).
• Off‑Label / Investigational Uses: Limited investigational reports in pulmonary hypertension and specific post‑prostatectomy ED under specialist supervision; these are not broadly approved practices and require informed consent.

When any off‑label use is considered, document a discussion of cardiovascular status, concurrent nitrates and safety monitoring, and record patient consent in line with Österreichische Apothekerkammer recommendations.

Composition And Brand Overview In Austria

Which brand will a patient find behind the name avana?

The active ingredient is avanafil (INN).

In Austria the marketed brand is Spedra® (Menarini) supplied in film‑coated tablets of 50 mg, 100 mg and 200 mg in foil blisters.

No topical or parenteral forms are available in major markets.

Packaging is commonly foil blister packs labelled with dose and batch number and storage recommended at 20–25°C with allowed excursions 15–30°C.

Austrian patients expect clear patient information leaflets in German and many Apotheken (including chains and independents) provide private counselling rooms for discreet advice.

Contraindications And Special Precautions

Before dispensing, pharmacists must always ask about nitrates and recent cardiac events.

Absolute contraindications include concurrent use with nitrates, use with guanylate cyclase stimulators such as riociguat, severe cardiovascular instability, severe hepatic impairment and known hypersensitivity to avanafil or excipients.

Relative cautions include anatomical penile deformities, predisposition to priapism, severe renal impairment, recent MI or stroke, unstable arrhythmias and hereditary retinal disorders such as retinitis pigmentosa.

1. Pharmacy Screening Checklist: Confirm nitrates; check e‑medikation for riociguat and CYP3A4 inhibitors; assess CV history; note hepatic/renal impairment.
2. Definitions: Absolute contraindication means the drug must not be used; relative contraindication means use with caution and monitoring.

Advise patients to avoid heavy alcohol before dosing and caution about driving if dizziness occurs.

Record interactions and relevant safety information in e‑medikation and alert prescribers or Sozialversicherung records when clinically necessary.

Dosing Guidelines In Austrian Practice

Common patient questions are about timing and dose adjustments.

The standard starting dose is 100 mg taken about 15 minutes before sexual activity, with a maximum frequency of once every 24 hours.

Adjust down to 50 mg for interaction risk or tolerability concerns, or up to 200 mg only if lower doses are ineffective and tolerated.

In mild to moderate renal impairment no initial adjustment is usually required; severe renal impairment requires caution due to limited data.

For hepatic impairment use a lower dose for mild to moderate disease and avoid use in severe hepatic impairment.

1. Step 1: Start 100 mg about 15 minutes before planned activity.
2. Step 2: If significant adverse effects, consider 50 mg and reassess.
3. Step 3: If ineffective and well tolerated, consider 200 mg under supervision.

Pharmacists should document dosing discussions in e‑medikation and offer discrete packaging and counselling, especially for elderly patients with cardiovascular comorbidity and concurrent antihypertensives.

Drug And Food Interactions

Which medicines or foods should a patient avoid while taking avanafil?

Avanafil is contraindicated with nitrates and should not be used with guanylate cyclase stimulators such as riociguat.

CYP3A4 inhibitors, for example some azole antifungals and macrolide antibiotics, increase avanafil exposure and may necessitate dose reduction or avoidance.

Grapefruit juice can increase avanafil levels via CYP3A4 inhibition, and heavy alcohol intake may worsen hypotension and impair efficacy.

Pharmacists should query OTC and herbal remedies at the point of supply, including St John’s wort and grapefruit, and advise against mixing with illicit nitrates such as poppers.

Check and document interactions in the e‑medikation system prior to dispensing.

Cultural Features And Patient Behaviour In Austria

How do Austrian attitudes and pharmacy types affect access to ED treatment?

Privacy, face‑to‑face counselling and discretion are highly valued by Austrian patients when seeking ED medicines.

Men in urban centres often prefer quick, on‑demand agents to preserve spontaneity, while rural populations rely heavily on independent Apotheken for personalised advice.

Cross‑border pharmacy trips to neighbouring countries occur for price or anonymity in some patients, and online forums in German and Austrian groups emphasise rapid onset and natural feeling.

• Persona: Urban Professional — prefers fast‑acting, discreet pharmacy delivery and private counselling rooms.
• Persona: Rural Regular — visits independent Apotheken, values relationship with pharmacist and may travel for stock or anonymity.
• Persona: Older Patient — often brings paper Rezepte from a urologist and prefers in‑person explanation of cardiovascular risks.

Regional differences in e‑medikation/e‑card uptake show higher urban use, while older men in some areas still prefer paper prescriptions from specialists.

Availability And Pricing In Austria

Where and how will patients pay for Spedra in Austria?

Spedra (avanafil) is prescription‑only and distributed through Apotheken, with Menarini supplying typical blister pack sizes of 50 mg, 100 mg and 200 mg.

Generics are uncommon in EU markets as of the latest summaries, so retail price is typically higher and most purchases are out‑of‑pocket since Sozialversicherung reimbursement is limited and assessed case‑by‑case.

Online pharmacy trends show increased demand for confidential ordering, but legal dispensing requires a valid Austrian prescription.

In our online pharmacy, avana is available without a prescription, with discreet delivery to Australia in 5‑14 days.

Pharmacists should verify e‑card or paper prescription, counsel on safe sourcing and document sales according to Österreichische Apothekerkammer guidance.

Comparable Drugs And Local Preferences

Patients usually want to compare avanafil with Viagra, Cialis or Levitra.

Major competitors in Austria are sildenafil, tadalafil and vardenafil.

Austrian patients often match drug choice to lifestyle: avanafil for fast‑acting on‑demand use, tadalafil for a longer window of spontaneity.

Pharmacists should balance clinical profile, interactions and cost when advising, using Österreichische Apothekerkammer resources to present options fairly.

Frequently Asked Questions From Austrian Pharmacies

1. How Quickly Does Spedra Work? Many patients report onset around 15 minutes; typical counselling is to take 100 mg about 15 minutes before activity.
2. Is It Covered By Sozialversicherung? Generally not routinely reimbursed; check individual Sozialversicherung rules for exceptions.
3. Can I Take It With Heart Medication? Not with nitrates; review all medications via e‑medikation and consult the prescriber for complex regimens.
4. What About Side Effects And Priapism? Common mild effects include headache, flushing and nasal congestion; priapism is rare but requires immediate emergency care if erection lasts longer than four hours.

Pharmacists should use a short referral flowchart to direct patients to GP or urologist when underlying causes, severe side effects or repeated treatment failures occur.

Offer private counselling rooms and document advice in e‑medikation according to professional standards.

Guidance For Correct Use And Pharmacy Counselling

What should a pharmacist cover in a brief private consultation?

1. Confirm valid prescription and patient identity, and note whether the patient has an e‑card entry.
2. Review current medications using e‑medikation and screen for contraindications, especially nitrates and riociguat.
3. Advise dosing: start 100 mg about 15 minutes before activity, adjust to 50 mg or 200 mg as needed, and do not exceed once in 24 hours.
4. Explain common side effects and emphasise when to seek urgent help (erection lasting >4 hours, chest pain, sudden vision loss).
5. Provide written Consumer Medicine Information (CMI) in German and offer discrete packaging and private counselling.
6. Document the counselling, any interaction checks and interventions in e‑medikation and notify the prescriber when significant interactions or safety concerns are found.

Use the Österreichische Apothekerkammer checklist for documentation and privacy practices and consider referral to urology when organic causes are suspected or oral therapy fails.

Delivery Across Australia

Final Practical Tips For Pharmacists And Patients

Keep a focused, private counselling session that covers contraindications, interactions and realistic expectations about onset and side effects.

Document all checks and advice in e‑medikation and use the Österreichische Apothekerkammer guidance for referrals and privacy.

Encourage patients to return for a follow‑up to assess efficacy and tolerability and to report any concerning adverse events promptly.

When discussing alternatives, present sildenafil, tadalafil and vardenafil objectively and help patients choose the option that best matches their lifestyle, comorbidities and cost considerations.